Levy Adam Scott

CIK 00016931343 companiesRADNOR, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001693134

Recent Transactions

44 trades

Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2026-02-19+53,300→ 53,300 total
Award
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-02-19+39,900→ 48,538 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2026-01-12$32.14/sh−10,758→ 8,638 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$43.50/sh−4,142→ 99,470 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$41.65/sh−12,952→ 112,097 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-11-11−6,613→ 4,888 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$46.88/sh−32,718→ 19,396 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-11-11−34,414→ 20,662 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$45.93/sh−38,900→ 52,114 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$15.44/sh+6,613→ 138,920 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-11-11−44,079→ 91,592 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$41.87/sh−11,295→ 126,610 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$16.00/sh+34,414→ 88,228 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$42.34/sh−8,485→ 103,612 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$42.68/sh−1,561→ 125,049 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$42.00/sh−1,015→ 137,905 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$10.20/sh+20,547→ 53,814 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$14.25/sh+44,079→ 132,307 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-11-11$45.18/sh−8,456→ 91,014 total
Exercise/Conversion
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-11-11−20,547→ 135,674 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-10-13$42.26/sh−3,392→ 116,865 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-10-13$41.90/sh−7,366→ 120,257 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-30$15.10/sh−8,425→ 132,934 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-30$14.70/sh−51,500→ 141,359 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-29$14.00/sh−807→ 192,859 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-28$14.04/sh−12,946→ 193,666 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-07-11$14.45/sh−10,758→ 206,612 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-04-11$12.06/sh−10,757→ 215,340 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2025-02-13+170,000→ 170,000 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-01-13$9.09/sh−10,657→ 226,197 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2025-01-13$9.63/sh−100→ 226,097 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-10-11$13.57/sh−10,757→ 236,854 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-07-11$13.14/sh−10,757→ 247,611 total
Sale
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2024-06-11$12.94/sh−96,815→ 255,462 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2024-02-13+200,000→ 200,000 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-03-17+20,000→ 20,000 total
Purchase
Mineralys Therapeutics, Inc.$MLYS
Common Stock
2023-02-14$16.00/sh+6,250→ 350,811 total
Award
Mineralys Therapeutics, Inc.$MLYS
Stock Option
2023-02-09+97,518→ 97,518 total
Award
Fresh Tracks Therapeutics, Inc.
Restricted Stock Units
2020-03-16$1.54/sh+20,000→ 20,000 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2019-02-06+74,000→ 74,000 total
Purchase
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2018-02-13$5.50/sh+9,090→ 10,540 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2018-01-31+80,000→ 80,000 total
Purchase
Viridian Therapeutics, Inc.\DE$VRDN
Common Stock
2017-06-22$7.55/sh+200→ 200 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (right to buy)
2017-02-16+87,500→ 87,500 total

Companies

Recent Filings

Address

150 N. RADNOR CHESTER RD. SUITE F200

RADNOR, PA, 19087

View on SEC.gov